[This review was originally posted at the Nieman Journalism Lab Lipitor Dosage, on April 16, 2010.]
Schmidt and Huffington’s advice for news execs: This week wasn’t a terribly eventful one in the future-of-journalism world, but a decent amount of the interesting stuff that was said came out of Washington D.C., site of the annual American Society of News Editors conference. The most talked-about session there was Sunday night’s keynote address by Google CEO Eric Schmidt, who told the news execs there that their industry is in trouble because it hasn’t found a way to sustain itself financially, not because its way of producing or delivering news is broken. “We have a business-model problem, My Lipitor experience, we don’t have a news problem,” Schmidt said.
After buttering the crowd up a bit, Schmidt urged them to produce news for an environment that’s driven largely by mobile devices, immediacy, and personalization, and he gave them a glimpse of what those priorities look like at Google. Politico and the Lab’s Megan Garber have summaries of the talk, Lipitor canada, mexico, india, and paidContent has video.
There were bunches more sessions and panels (American Journalism Review’s Rem Rieder really liked them), but two I want to highlight in particular. One was a panel with New York Times media critic David Carr, new-media titan Ariana Huffington and the Orlando Sentinel’s Mark Russell on the “24/7 news cycle.” The Lab’s report on the session focused on four themes, Lipitor dangers, with one emerging most prominently — the need for context to make sense out of the modern stream of news. St. Petersburg Times media critic Eric Deggans and University of Maryland student Adam Kerlin also zeroed in on the panelists’ call to develop deeper trust and participation among readers.
The second was a presentation by Allbritton’s Steve Buttry that provides a perfect fleshing-out of the mobile-centric vision Schmidt gave in his keynote, Lipitor Dosage. Poynter’s Damon Kiesow had a short preview, and Buttry has a longer one that includes a good list of practical suggestions for newsrooms to start a mobile transformation. (He also has slides from his talk, and he posted a comprehensive mobile strategy for news orgs back in November, buy Lipitor no prescription, if you want to dive in deep.)
There was plenty of other food for thought, too: Joel Kramer of the Twin Cities nonprofit news org MinnPost shared his experiences with building community, and one “where do we go from here?” panel seemed to capture news execs’ ambivalence about the future of their industry. Students from local universities also put together a blog on the conference with a Twitter stream and short recaps of just about every session, Lipitor brand name, and it’s worth a look-through. Two panels of particular interest: One on government subsidies for news and another with Kelly McBride of Poynter’s thoughts on the “fifth estate” of citizen journalists, bloggers, nonprofits and others.
Is a closed iPad bad for news?: In the second week after the iPad’s release, much of the commentary centered once again on Apple’s control over the device. Lipitor Dosage, In a long, thoughtful post, Media watcher Dan Gillmor focused on Apple’s close relationship with The New York Times, posing a couple of arresting questions for news orgs creating iPad apps: Does Apple have the unilateral right to remove your app for any reason it wants, and why are you OK with that kind of control?
On Thursday he got a perfect example, when the Lab’s Laura McGann reported that Pulitzer-winning cartoonist Mark Fiore’s iPhone app was rejected in December because it “contains content that ridicules public figures.” Several other folks echoed Gillmor’s alarm, with pomo blogger Terry Heaton asserting that the iPad is a move by the status quo to retake what it believes is its rightful place in the culture. O’Reilly Radar’s Jim Stogdill says that if you bought an iPad, Lipitor pictures, you aren’t really getting a computer so much as “a 16GB Walmart store shelf that fits on your lap … and Apple got you to pay for the building.” And blogging/RSS/podcasting pioneer Dave Winer says the iPad doesn’t change much for news because it’s so difficult to create media with.
But in a column for The New York Times, web thinker Steven Johnson adds an important caveat: While he’s long been an advocate of open systems, he notes that the iPhone software platform has been the most innovative in the history in computing, despite being closed. Lipitor reviews, He attributes that to simpler use for its consumers, as well as simpler tasks for developers. While Johnson still has serious misgivings about the Apple’s closed policy from a control standpoint, he concludes that “sometimes, if you get the conditions right, a walled garden can turn into a rain forest.”
In related iPad issues, Lipitor price, coupon, DigitalBeat’s Subrahmanyam KVJ takes a step back and looks at control issues with Apple, Facebook, Twitter and Google. Florida j-prof Mindy McAdams has a detailed examination of the future of HTML5 and Flash in light of Adobe’s battle with Adobe over the iPad. Oh yeah, and to the surprise of no one, a bunch of companies, including Google, are developing iPad competitors.
News editors’ pessimism: A survey released Monday by the Pew Research Center’s Project for Excellence in Journalism presented a striking glimpse into the minds of America’s news executives, Lipitor Dosage. Lipitor dosage, Perhaps most arresting (and depressing) was the finding that nearly half of the editors surveyed said that without a significant new revenue stream, their news orgs would go under within a decade, and nearly a third gave their org five years or less.
While some editors are looking at putting up paywalls online as that new revenue source, the nation’s news execs aren’t exactly overwhelmed at that prospect: 10 percent are actively working on building paywalls, and 32 percent are considering it. Much higher percentages of execs are working on online advertising, cheap Lipitor, non-news products, local search and niche products as revenue sources.
One form of revenue that most news heads are definitely not crazy about is government subsidy: Three quarters of them, including nearly 90 percent of newspaper editors, had “serious reservations” about that kind of funding (the highest level of concern they could choose). Effects of Lipitor, The numbers were lower for tax subsidies, but even then, only 19 percent said they’d be open to it.
The report itself makes for a pretty fascinating read, and The New York Times has a good summary, too. The St, Lipitor blogs. Pete Times’ Eric Deggans wonders Lipitor Dosage, how bad things would have to get before execs would be willing to accept government subsidies (pretty bad), and the Knight Digital Media Center’s Amy Gahran highlights the statistics on editors’ thoughts on what went wrong in their industry.
Twitter rolls out paid search: This week was a big one for Twitter: We finally found out some of the key stats about the microblogging service, including how many users it has (105,779,710), and the U.S. Library of Congress announced it’s archiving all of everyone’s tweets, ever.
But the biggest news was Twitter’s announcement that it will implement what it calls Promoted Tweets — its first major step toward its long-anticipated sustainable revenue plan. As The New York Times explains, Promoted Tweets are paid advertisements that will show up first when you search on Twitter and, Lipitor samples, down the road, as part of your regular stream if they’re contextually relevant. Or, in Search Engine Land’s words, it’s paid search, at least initially.
Search blogger John Battelle has some initial thoughts on the move: He thinks Twitter seems to be going about things the right way, buy no prescription Lipitor online, but the key shift is that this “will mark the first time, ever, that users of the service will see a tweet from someone they have not explicitly decided to follow.” Alex Wilhelm of The Next Web gives us a helpful roadmap of where Twitter’s heading with all of its developments.
Anonymity and comments: A quick addendum to last month’s discussion about anonymous comments on news sites (which really has been ongoing since then, just very slowly): The New York Times’ Richard Perez-Pena wrote about many news organizations’ debates over whether to allow anonymous comments, Lipitor class, and The Guardian’s Nigel Willmott explained why his paper’s site will still include anonymous commenting.
Meanwhile, former Salon-er Scott Rosenberg told media companies that they’d better treat it like a valuable conversation if they want it to be one (that means managing and directing it), rather than wondering what the heck’s the problem with those crazy commenters. And here at The Lab, Joshua Benton found that when the blogging empire Gawker made its comments a tiered system, their quality and quantity improved.
Reading roundup: This week I have three handy resources, three ideas worth pondering, and one final thought.
Three resources: If you’re looking for a zoomed-out perspective on the last year or two in journalism in transition, Daniel Bachhuber’s “canonical” reading list is a fine place to start. PaidContent has a nifty list of local newspapers that charge for news online, and Twitter went public with Twitter Media, a new blog to help media folks use Twitter to its fullest.
Three ideas worth pondering: Scott Lewis of the nonprofit news org Voice of San Diego talks to the Lab about how “explainers” for concepts and big news stories could be part of their business model, analysts Frederic Filloux and Alan Mutter take a close look at online news audiences and advertising, and Journal Register Co, Lipitor Dosage. head John Paton details his company’s plan to have one newspaper produce one day’s paper with only free web tools. (Jeff Jarvis, an adviser, shows how it might work and why he’s excited.)
One final thought: British j-prof Paul Bradshaw decries the “zero-sum game”attitude by professional journalists toward user-generated content that views any gain for UGC as a loss for the pros. He concludes with a wonderful piece of advice: “If you think the web is useless, make it useful. … Along the way, you might just find that there are hundreds of thousands of people doing exactly the same thing.”.
Similar posts: Retin A No Rx. Flagyl No Rx. Armour For Sale. Purchase Cipro online no prescription. Synthroid class. Tramadol pharmacy.
Trackbacks from: Lipitor Dosage. Lipitor Dosage. Lipitor Dosage. Lipitor long term. Lipitor mg. Lipitor used for.